ABT-639 + pregabalin + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetic Neuropathic Pain
Conditions
Diabetic Neuropathic Pain
Trial Timeline
Apr 1, 2011 → Oct 1, 2011
NCT ID
NCT01345045About ABT-639 + pregabalin + Placebo
ABT-639 + pregabalin + Placebo is a phase 2 stage product being developed by AbbVie for Diabetic Neuropathic Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT01345045. Target conditions include Diabetic Neuropathic Pain.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01345045 | Phase 2 | Completed |
Competing Products
20 competing products in Diabetic Neuropathic Pain